Trial Profile
A retrospective trial to assess chemotherapy in patients with metastatic colorectal cancer who initially received regorafenib
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Aug 2015
Price :
$35
*
At a glance
- Drugs Regorafenib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 10 Aug 2015 New trial record